Quantcast

Latest Neuroprotection Stories

2008-10-14 09:00:45

Neuronascent, a small-molecule central nervous system drug discovery company, has received funding from multiple sources to further the development of its neurogenic compounds targeting Alzheimer's disease, depression and ischemia.

2008-10-13 12:00:42

CLARKSVILLE, Md., Oct. 13 /PRNewswire/ -- Neuronascent, Inc. (http://www.neuronascent.com/) announced today that the Company has received funding from multiple sources to further the development of its novel, neurogenic compounds targeting Alzheimer's disease, depression and ischemia.

2008-10-09 18:00:37

U.S. and Japanese medical scientists say they've found giving rats a certain hormone immediately after a heart attack significantly reduced coronary damage.

2008-10-02 15:01:05

WESTON, Mass., Oct. 2 /PRNewswire/ -- Weston Medical Publishing today announced publication of the first issue of Journal of Neurodegeneration and Regeneration.

2008-09-09 21:00:07

German scientists say a protein hormone used to increase blood production in medical treatments and boost athletic performance might also improve memory.

2008-09-05 06:00:23

Neurologix, a biotechnology company engaged in the development of gene therapies for the brain and central nervous system, and Aegera Therapeutics, a private clinical stage company focused on oncology and neuropathic pain, have executed an exclusive license agreement.

2008-08-21 09:01:14

Biovail Corporation has appointed Neil Sussman as vice president of neurologic and psychiatric development of Biovail Technologies. Dr Sussman brings a wealth of business and academic experience in the field of neurology and other central nervous system (CNS) disorders to Biovail.

2008-08-20 09:01:30

Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced the appointment of Dr. Neil M. Sussman as Vice-President, Neurologic and Psychiatric Development of Biovail Technologies, Ltd. The appointment is effective immediately. Dr.

2008-07-30 15:01:17

CHICAGO, July 30 /PRNewswire-FirstCall/ -- ANAVEX Life Sciences Corp.

2008-06-29 06:01:42

By Mercier, Marie Le Mathieu, Veronique; Haibe-Kains, Benjamin; Bontempi, Gianluca; Mijatovic, Tatjana; Decaestecker, Christine; Kiss, Robert; Lefranc, Florence Abstract Galectin (Gal) 1 is a hypoxia-regulated proangiogenic factor that also directly participates in glioblastoma cell migration.


Word of the Day
cowpooling
  • The practice of two or more parties jointly purchasing all or part of a butchered cow and dividing the meat between them.
The word 'cowpooling' was formed on the model of 'carpooling'.